
Mark Massaro
Stock Analyst at BTIG
(4.39)
# 1,289
Out of 5,189 analysts
1063
Total ratings
39.6%
Success rate
8%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLLN BillionToOne | Reiterated: Buy | $130 | $89.92 | +44.57% | 8 | Nov 19, 2026 | |
| WGS GeneDx Holdings | Reiterated: Buy | $85 | $45.46 | +86.98% | 39 | Nov 19, 2026 | |
| XGN Exagen | Reiterated: Buy | $9 | $3.61 | +149.31% | 27 | Nov 11, 2026 | |
| CSTL Castle Biosciences | Reiterated: Buy | $44 → $52 | $32.86 | +58.25% | 36 | Nov 9, 2026 | |
| NTRA Natera | Reiterated: Buy | $430 | $273.40 | +57.28% | 82 | Nov 6, 2026 | |
| ADPT Adaptive Biotechnologies | Reiterated: Buy | $34 | $27.93 | +21.73% | 45 | Nov 5, 2026 | |
| SOPH SOPHiA GENETICS | Reiterated: Buy | $9 | $6.23 | +44.46% | 20 | Nov 3, 2026 | |
| CERS Cerus | Reiterated: Buy | $4 | $1.85 | +116.22% | 26 | Nov 2, 2026 | |
| TEM Tempus AI | Reiterated: Buy | $80 → $100 | $54.04 | +85.05% | 13 | Nov 2, 2026 | |
| CAI Caris Life Sciences | Reiterated: Buy | $33 → $38 | $17.58 | +116.15% | 9 | Oct 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $74 → $81 | $70.00 | +15.71% | 36 | Oct 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $195 → $210 | $145.83 | +44.00% | 51 | Oct 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.97 | - | 25 | Oct 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.1074 | - | 16 | Oct 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $28 | $14.82 | +88.93% | 36 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $14.27 | - | 39 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $5 | $7.46 | -32.98% | 28 | Sep 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.37 | - | 30 | Aug 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $9.36 | +81.62% | 1 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.5 | $0.3727 | +570.78% | 25 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $8 | $7.63 | +4.85% | 13 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 | $79.11 | +102.25% | 12 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $830 → $800 | $676.21 | +18.31% | 60 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.8222 | n/a | 19 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $3.45 | n/a | 20 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0009 | n/a | 53 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 25 | Dec 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $75 | $8.32 | n/a | 57 | Nov 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $8 | $3.46 | n/a | 48 | Nov 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $1.96 | n/a | 11 | Nov 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $300 → $310 | $192.82 | n/a | 50 | Oct 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $173 → $170 | $367.13 | n/a | 43 | Oct 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $112 → $113 | $258.28 | n/a | 41 | Oct 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2.3 → $1 | $0.09195 | n/a | 13 | May 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $4 | $16.23 | n/a | 4 | Feb 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $149 → $145 | $212.78 | n/a | 2 | May 7, 2015 |
BillionToOne
Nov 19, 2026
Reiterated: Buy
Price Target: $130
Current: $89.92
Upside: +44.57%
GeneDx Holdings
Nov 19, 2026
Reiterated: Buy
Price Target: $85
Current: $45.46
Upside: +86.98%
Exagen
Nov 11, 2026
Reiterated: Buy
Price Target: $9
Current: $3.61
Upside: +149.31%
Castle Biosciences
Nov 9, 2026
Reiterated: Buy
Price Target: $44 → $52
Current: $32.86
Upside: +58.25%
Natera
Nov 6, 2026
Reiterated: Buy
Price Target: $430
Current: $273.40
Upside: +57.28%
Adaptive Biotechnologies
Nov 5, 2026
Reiterated: Buy
Price Target: $34
Current: $27.93
Upside: +21.73%
SOPHiA GENETICS
Nov 3, 2026
Reiterated: Buy
Price Target: $9
Current: $6.23
Upside: +44.46%
Cerus
Nov 2, 2026
Reiterated: Buy
Price Target: $4
Current: $1.85
Upside: +116.22%
Tempus AI
Nov 2, 2026
Reiterated: Buy
Price Target: $80 → $100
Current: $54.04
Upside: +85.05%
Caris Life Sciences
Oct 27, 2026
Reiterated: Buy
Price Target: $33 → $38
Current: $17.58
Upside: +116.15%
Oct 27, 2026
Reiterated: Buy
Price Target: $74 → $81
Current: $70.00
Upside: +15.71%
Oct 27, 2026
Reiterated: Buy
Price Target: $195 → $210
Current: $145.83
Upside: +44.00%
Oct 20, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.97
Upside: -
Oct 19, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.1074
Upside: -
Oct 6, 2026
Upgraded: Buy
Price Target: $28
Current: $14.82
Upside: +88.93%
Oct 6, 2026
Downgraded: Hold
Price Target: n/a
Current: $14.27
Upside: -
Sep 4, 2026
Reiterated: Sell
Price Target: $5
Current: $7.46
Upside: -32.98%
Aug 24, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.37
Upside: -
Aug 17, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $9.36
Upside: +81.62%
Aug 17, 2026
Reiterated: Buy
Price Target: $2.5
Current: $0.3727
Upside: +570.78%
Aug 11, 2026
Upgraded: Buy
Price Target: $8
Current: $7.63
Upside: +4.85%
Feb 26, 2026
Reiterated: Buy
Price Target: $160
Current: $79.11
Upside: +102.25%
Feb 3, 2026
Reiterated: Buy
Price Target: $830 → $800
Current: $676.21
Upside: +18.31%
Aug 22, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.8222
Upside: n/a
May 20, 2024
Reiterated: Buy
Price Target: $2
Current: $3.45
Upside: n/a
Sep 22, 2023
Rated: Hold
Price Target: n/a
Current: $0.0009
Upside: n/a
Dec 6, 2019
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Nov 17, 2019
Reiterated: Buy
Price Target: $70 → $75
Current: $8.32
Upside: n/a
Nov 10, 2019
Reiterated: Hold
Price Target: $7 → $8
Current: $3.46
Upside: n/a
Nov 6, 2019
Reiterated: Buy
Price Target: $35
Current: $1.96
Upside: n/a
Oct 24, 2019
Reiterated: Hold
Price Target: $300 → $310
Current: $192.82
Upside: n/a
Oct 24, 2019
Reiterated: Hold
Price Target: $173 → $170
Current: $367.13
Upside: n/a
Oct 22, 2019
Reiterated: Buy
Price Target: $112 → $113
Current: $258.28
Upside: n/a
May 23, 2018
Downgraded: Hold
Price Target: $2.3 → $1
Current: $0.09195
Upside: n/a
Feb 9, 2016
Reiterated: Hold
Price Target: $8 → $4
Current: $16.23
Upside: n/a
May 7, 2015
Reiterated: Hold
Price Target: $149 → $145
Current: $212.78
Upside: n/a